The Role of Sex Chromosomes in Cardiovascular Disease
Overview
Sex chromosomes contribute significantly to sex differences in cardiovascular disease (CVD) beyond hormonal influences. Mosaic loss of the Y chromosome (mLoY) is strongly linked to heart failure and related mechanisms, while X chromosome inactivation escape may explain female-specific gene expression affecting CVD risk.
Background
Cardiovascular disease remains the leading cause of death globally, with notable differences in clinical presentation and outcomes between men and women. Traditionally, these differences were attributed to sex hormones, but recent evidence highlights the direct role of sex chromosomes in cardiovascular health. The X chromosome contains numerous genes involved in immune regulation, while the Y chromosome, though smaller, influences male-specific functions and non-reproductive tissues. Understanding these genetic contributions is crucial for elucidating sex-specific disease mechanisms.
Data Highlights
The X chromosome harbors approximately 850 protein-coding genes, including ∼10% of all human miRNAs, whereas the Y chromosome contains only 47 genes. Mosaic loss of the Y chromosome (mLoY) is associated with heart failure and mechanisms such as myocardial fibrosis and cardiac macrophage infiltration mediated by transforming growth factor beta signalling. Sex chromosomes are often excluded from genome-wide association studies due to technical challenges, limiting comprehensive genetic insights.
Key Findings
Mosaic loss of the Y chromosome (mLoY) is a well-characterized mechanism linking sex chromosomes to cardiovascular disease, particularly heart failure.
mLoY contributes to myocardial fibrosis and cardiac macrophage infiltration via transforming growth factor beta signalling pathways.
X chromosome inactivation escape leads to higher expression of specific X-linked genes in females, potentially explaining sex differences in CVD susceptibility.
Sex chromosomes influence cardiovascular health independently of sex hormones, affecting non-gonadal tissues including the heart.
Technical and structural complexities have limited inclusion of sex chromosomes in genetic studies, hindering full understanding of their role in CVD.
Clinical Implications
Recognition of mLoY as a biomarker or causal factor in cardiovascular disease may improve risk stratification and guide therapeutic interventions, especially in men. Understanding X chromosome inactivation escape mechanisms could inform sex-specific treatment approaches in women. Incorporating sex chromosome analysis into genetic studies may enhance precision medicine strategies for CVD.
Conclusion
Sex chromosomes play a complex and significant role in cardiovascular disease beyond hormonal effects, influencing disease susceptibility and progression through genetic and molecular mechanisms. Further research is essential to fully elucidate these pathways and translate findings into clinical practice.
References
Review Article 2024 -- The Role of Sex Chromosomes in Cardiovascular Disease
